Answers are grounded in this paper and cite their sources.
Experiments reveal MRAP2 boosts signaling in melanocortin-4 and ghrelin receptors, with obesity variants reducing effectiveness in people.
• MRAP2 disrupts GPCR oligomers to preferentially form a 1:1 complex with GPCRs • The MRAP2 cytoplasmic tail modifies GPCR constitutive activity to enhance signaling • GHSR TM5–TM7 are important for MRAP2 interactions and MRAP2-mediated signaling • Obesity-associated MRAP2 variants enhance GPCR internalization to reduce signaling MRAP2 disrupts GPCR oligomers to preferentially form a 1:1 complex with GPCRs The MRAP2 cytoplasmic tail modifies GPCR constitutive activity to enhance signaling GHSR TM5–TM7 are important for MRAP2 interactions and MRAP2-mediated signaling Obesity-associated MRAP2 variants enhance GPCR internalization to reduce signaling The melanocortin-2 receptor accessory protein (MRAP) family interacts with and regulates the signaling of diverse G protein-coupled receptors (GPCRs). MRAP2 modifies the signaling of three distinct GPCRs, melanocortin-4 receptor (MC4R), MC3R, and ghrelin receptor (GHSR), all essential for appetite regulation. The nature of MRAP2/GPCR complexes and whether there are shared mechanisms for complex assembly, critical structural regions, or consistent effects on receptor signaling remains unknown. Here, we show that all three GPCRs preferentially interact with MRAP2 as 1:1 complexes and MRAP2 binding disrupts GPCR homodimerization. MRAP2 interacts with shared receptor transmembrane regions to promote GPCR signaling and impairs β-arrestin-2 recruitment to prolong signaling and delay internalization. Deletion of the MRAP2 cytoplasmic region impairs GPCR signaling by modulating constitutive activity. Human MRAP2 variants associated with overweight/obesity modify the constitutive activity of all three GPCRs. Thus, MRAP2 regulates GPCR function using shared molecular mechanisms, and we provide further evidence for the importance of GHSR constitutive activity.
No takes yet. Share an insight, caveat, or question.
Jamaluddin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: